
The Savannah Regional Health Directorate has launched a renewed Human Papillomavirus (HPV) vaccination campaign to protect young girls against cervical cancer. Targeting girls between the ages of 9 and 14 across seven districts, the initiative aims to curb the high mortality rate associated with the disease in Ghana. Health officials are focusing on intensified community mobilization and education to ensure that every eligible girl within the region receives the life-saving vaccine during the designated period.
Cervical cancer remains a significant public health challenge in Ghana, accounting for approximately 3,000 new cases and 2,000 deaths every year. To address this, the Ghana Health Service (GHS) has prioritized vaccination as a primary preventive measure. In the Savannah Region, the campaign initially set a target to reach 48,835 girls. While progress has been made with 42,167 girls already vaccinated, the Directorate is determined to close the gap and reach the remaining thousands of eligible children who are currently unprotected.
The upcoming phase of the campaign is scheduled to run from October 19 to October 23, 2026. During this five-day window, health workers will carry out intensive outreach across all seven districts of the region. Dr. John Ekow Otoo, representing the regional directorate, has emphasized that the HPV vaccine is safe, effective, and a critical tool in preventing cancer-related deaths in the future. He has reassured the public that the vaccine has undergone rigorous testing to ensure its safety for the target age group.
Central to the success of this initiative is the active involvement of parents, guardians, and local stakeholders. The GHS is making public education a priority to combat misinformation that can often lead to vaccine hesitancy. By fostering community acceptance and providing clear information regarding the benefits of the HPV vaccine, the Savannah Regional Health Directorate aims to ensure that no girl is left behind, ultimately reducing the regional burden of cervical cancer for future generations.